Identification of an intronic cis-acting element in the human dopamine transporter gene

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5393-5399

  Zhao, Ying ^a,b,c   Zhou, Yanhong ^a,b   Xiong, Nian ^a,b,d   Lin, Zhicheng ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c XINXIANG MEDICAL UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell type dependent; DAT; Medication target; Primate specific; Promoter activity; SLC6A3

Indexed keywords

CIS ACTING ELEMENT; DOPAMINE TRANSPORTER; NUCLEAR PROTEIN; SLC6A3 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DOPAMINE TRANSPORTER GENE; DOWN REGULATION; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE INSERTION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRON; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DNA BINDING; BASE PAIRING; CELL LINE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40;

PRIMATES;

BASE PAIRING; BASE SEQUENCE; CELL LINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40;

EID: 84863752275     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1339-4     Document Type: Article

References (28)

1. Hitri A, Hurd YL, Wyatt RJ, Deutsch SI (1994) Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance. Clin Neuropharmacol 17:1-22
2. Ohyama K, Sogawa C, Sogawa N, Morita K, Dohi T, Kitayama S (2010) Nicotine stimulates transcriptional activity of the human dopamine transporter gene. Neurosci Lett 471:34-37
3. Stevens SE, Kumsta R, Kreppner JM, Brookes KJ, Rutter M, Sonuga-Barke EJ (2009) Dopamine transporter gene polymorphism moderates the effects of severe deprivation on ADHD symptoms: developmental continuities in gene-environment interplay. Am J Med Genet B 150B:753-761
4. Lin Z, Canales JJ, Björgvinsson T, Thomsen M, Qu H, Liu QR, Torres GE, Caine SB (2011) Monoamine transporters vulnerable and vital doorkeepers. Prog Mol Biol Transl Sci 98:1-46
5. Bannon MJ, Whitty CJ (1997) Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology 48:969-977
6. Hurd YL, Pristupa ZB, Herman MM, Niznik HB, Kleinman JE (1994) The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience 63:357-362
7. Lee KH, Kwak YD, Kim DH, Chang MY, Lee YS (2004) Human zinc finger protein 161, a novel transcriptional activator of the dopamine transporter. BiochemBiophys ResCommun 313:969-976
8. Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ (1999) Characterization of the 50-flanking region of the human dopamine transporter gene. Brain Res Mol Brain Res 74:167-174
9. Wang J, Michelhaugh SK, Bannon MJ (2007) Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells. Eur J Neurosci 25:1982-1986
10. Xing G, Zhang L, Heynen T, Li XL, Smith MA, Weiss SR, Feldman AN, Detera-Wadleigh S, Chuang DM, Post RM (1997) Rat nurr1 is prominently expressed in perirhinal cortex, and differentially induced in the hippocampal dentate gyrus by electroconvulsive vs. kindled seizures. Brain Res Mol Brain Res 47:251-261
11. Yokoro K, Yanagidani A, Obata T, Yamamoto S, Numoto M (1998) Genomic cloning and characterization of the mouse POZ/ zinc-finger protein ZF5. Biochem Biophys Res Commun 246: 668-674
12. Greenwood TA, Kelsoe JR (2003) Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511-520
13. Kouzmenko AP, Pereira AM, Singh BS (1997) Intronic sequences are involved in neural targeting of human dopamine transporter gene expression. Biochem Biophys Res Commun 240: 807-811
14. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408
15. Lin Z, Walther D, Yu XY, Li S, Drgon T, Uhl GR (2005) SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism. Hum Mol Genet 14:1393-1404
16. Lin Z, Zhao Y, Chung CY, Zhou Y, Xiong N, Glatt CE, Isacson O (2010) High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life. FASEB J 24:2191-2200
17. Wang J, Bannon MJ (2005) Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J Neurochem 93:474-482
18. Bai Q, Burton EA (2009) Cis-acting elements responsible for dopaminergic neuron-specific expression of zebrafish slc6a3 (dopamine transporter) in vivo are located remote from the transcriptional start site. Neuroscience 164:1138-1151
19. Chen YC, Lin SI, Chen YK, Chiang CS, Liaw GJ (2009) The Torso signaling pathway modulates a dual transcriptional switch to regulate tailless expression. Nucleic Acids Res 37:1061-1072
20. Adkins NL, Hagerman TA, Georgel P (2006) GAGA protein: a multi-faceted transcription factor. Biochem Cell Biol 84:559-567
21. Gonzalez-Lamothe R, Boyle P, Dulude A, Roy V, Lezin- Doumbou C, Kaur GS, Bouarab K, Després C, Brisson N (2008) The transcriptional activator Pti4 is required for the recruitment of a repressosome nucleated by repressor SEBF at the potato PR- 10a gene. Plant Cell 20:3136-3147
22. Ikeda M, Mitsuda N, Ohme-Takagi M (2009) Arabidopsis WUSCHEL is a bifunctional transcription factor that acts as a repressor in stem cell regulation and as an activator in floral patterning. Plant Cell 21:3493-3505
23. Forsberg M, Westin G (1991) Enhancer activation by a single type of transcription factor shows cell type dependence. EMBO J 10:2543-2551
24. Glaser G, Vogel M, Wolf H, Niller HH (1998) Regulation of the Epstein-Barr viral immediate early BRLF1 promoter through a distal NF1 site. Arch Virol 143:1967-1983
25. Hall FS, Sora I, Uhl GR (2003) Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. Neuropsychopharmacology 28:620-628
26. Morice E, Denis C, Giros B, Nosten-Bertrand M (2010) Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice. Psychopharmacology 208:57-66
27. Salahpour A, Medvedev IO, Beaulieu JM, Gainetdinov RR, Caron MG (2007) Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol Psychiatry 61:65-69
28. Savelieva KV, Caudle WM, Findlay GS, Caron MG, Miller GW (2002) Decreased ethanol preference and consumption in dopamine transporter female knock-out mice. Alcohol Clin Exp Res 26:758-764